Abstract
Studies have shown interventions that reduce total and low-density lipoprotein cholesterol levels also decrease subsequent coronary heart disease (CHD) and stroke events in those with a history of CHD. However, it is uncertain whether pharmacological alteration of lipid levels in those with a history of cerebrovascular disease can prevent recurrence of either stroke or subsequent cardiovascular events.
| Original language | English |
|---|---|
| Pages (from-to) | e622-e623 |
| Number of pages | 2 |
| Journal | Stroke |
| Volume | 40 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2009 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver